Table 2.

Associations between primary predictors and SI status.

Correlate	N (case, control)	OR	95% CI	p-Value	aORb	95% CI	p-Value
Plasma neutralization breadth	13, 39	1.00	0.52–1.93	1.00	1.35	0.73–2.53	0.33
Plasma neutralization potency	13, 39	0.93	0.75–1.15	0.51	0.99	0.74–1.32	0.94
Plasma ADCC activity	20, 60	0.44	0.06–3.10	0.41	0.74	0.09–6.00	0.78
Cervical ADCC activity	17, 51	1.16	0.51–2.63	0.73	0.18	0.52–2.67	0.70
Plasma V1V2 IgG bindinga
ZM109	20, 60	1.00	0.31–3.18	1.00	0.96	0.30–3.04	0.94
ZM53	20, 60	0.89	0.24–3.33	0.89	0.97	0.26–3.63	0.96
Case A2	20, 60	1.00	0.27–3.69	1.00	1.05	0.27–4.08	0.94
Average	20, 60	0.79	0.48–1.29	0.34	0.64	0.20–2.06	0.46
Plasma gp140 IgA binding	20, 60	0.93	0.58–1.49	0.78	0.85	0.51–1.41	0.52

ADCC = antibody-dependent cell-mediated cytotoxicity, aOR = adjusted odds ratio, CI = confidence interval, OR = odds ratio, SI = superinfection, VL = viral load.

^aDichotomized detectable vs. undetectable.

^bAdjusted for VL.